CR UK makes further cuts in COVID’s wake
The charity is slashing £45 million from its research budget
Read More
Author: Selina McKee
World first as UK launches COVID-19 vaccination programme
A 90 year-old woman in Coventry has become the first person in the UK to be given the vaccine
Read More
Calquence shows long-term efficacy and tolerability in MCL
Patients with relapsed or refractory mantle cell lymphoma (MCL) treated with AstraZeneca’s Calquence remained progression free for a median of 22 months
Read More
Research highlights benefit of telemedicine for stroke treatment
Around one in five stroke patients could go undiagnosed with the tests currently used by paramedics
Read More
UK launch for Vagirux
The drug is administered intravaginally as a local oestrogen therapy for treatment of vaginal atrophy due to oestrogen deficiency.
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
